Extended-spectrum β-lactamases in Enterobacter cloacae: Underestimated but clincially significant!

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 5, 2003, Pages 1316-1317

  Crowley, B ^a   Ratcliffe, G ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Enterobacter cloacae; ESBLs

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; MONOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; LETTER; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEPTICEMIA;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS;

EID: 0038440748     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg206     Document Type: Letter

References (6)

1. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clinical Microbiology Reviews 14, 933-51.
2. Livermore, D. M. & Brown, D. F. (2001). Detection of β-lactamase-mediated resistance. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 59-64.
3. National Committee for Clinical Laboratory Standards. (2000). Performance Standards for Antimicrobial Susceptibility Testing: Tenth Informational Supplement, Document M100-S10. NCCLS, Wayne, PA, USA.
4. Sirot, J. (1996). Detection of extended-spectrum plasmid-mediated β-lactamases by disk diffusion. Clinical Microbiology and Infection 2, Suppl. 1, S35-9.
5. Vercauteren, E., Descheemaeker, P., Ieven, M., Sanders, C. & Goosens, H. (1997). Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. Journal of Clinical Microbiology 35, 2191-7.
6. Rice, L. B. & Bonomo R. A. (2000). β-Lactamases: which ones are clinically important? Drug Resistance Updates 3, 178-89.